Shionogi & Co Liabilities 2024

Shionogi & Co Aktienanalyse

What does Shionogi & Co do?

The company Shionogi & Co Ltd is a Japanese pharmaceutical company based in Osaka. It was founded in 1878 and has since become a significant player in the industry. It currently employs over 6,000 employees worldwide and is listed on the Tokyo Stock Exchange. Shionogi is divided into several business segments that offer different products and services. The largest segment is the pharmaceutical division, which specializes in the development and marketing of drugs. The company has strong expertise in infectious diseases, pain management, and oncology, and operates in many countries worldwide. One flagship product is the antibiotic Cefditoren, used to treat various bacterial infections. In addition to the pharmaceutical division, Shionogi is also active in other areas. For example, the company offers diagnostic and laboratory services, operating multiple labs in Japan and other countries. Another business segment is the production and marketing of nutritional supplements, sold in Japan, China, and the USA. Shionogi's business model is based on extensive research and development, as well as strong brand positioning. The company invests a significant portion of its revenue each year in the research and development of new drugs and better treatment options for existing diseases. Thanks to the high quality of its products and strong brand, the company has a loyal customer base. In recent years, Shionogi has focused on international expansion opportunities and has expanded its activities in various regions. For example, it has partnered with US pharmaceutical company Purdue Pharma to develop and market a novel pain medication. Shionogi's annual revenue is around 1.5 billion euros. The company is particularly strong in Japan and other Asian countries, but is also active in the US and Europe. In the coming years, Shionogi aims to further expand its international business and solidify its position as a significant player in the industry. Key focuses will be on the launch of new products and finding treatments for previously incurable diseases. Overall, Shionogi is an innovative and successful company that utilizes its expertise in the pharmaceutical industry in various ways. With its dedicated employees and strong brand, it will continue to play an important role in the industry. Shionogi & Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Shionogi & Co's Liabilities

Shionogi & Co's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Shionogi & Co's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Shionogi & Co's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Shionogi & Co's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Shionogi & Co’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Shionogi & Co stock

What is the level of liabilities of Shionogi & Co this year?

Shionogi & Co has a debt balance of 181.59 B JPY this year.

What were the liabilities of Shionogi & Co compared to the previous year?

The liabilities of Shionogi & Co have increased by 3.8% increased compared to the previous year.

What are the consequences of high debt for investors of Shionogi & Co?

High liabilities can pose a risk for investors of Shionogi & Co, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Shionogi & Co?

Low liabilities mean that Shionogi & Co has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Shionogi & Co affect the company?

An increase in liabilities of Shionogi & Co can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Shionogi & Co affect the company?

A decrease in the liabilities of Shionogi & Co can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Shionogi & Co?

Some factors that can influence the liabilities of Shionogi & Co include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Shionogi & Co so important for investors?

The liabilities of Shionogi & Co are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Shionogi & Co take to modify the liabilities?

To change its liabilities, Shionogi & Co can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Shionogi & Co pay?

Over the past 12 months, Shionogi & Co paid a dividend of 113.33 JPY . This corresponds to a dividend yield of about 5.33 %. For the coming 12 months, Shionogi & Co is expected to pay a dividend of 117.56 JPY.

What is the dividend yield of Shionogi & Co?

The current dividend yield of Shionogi & Co is 5.33 %.

When does Shionogi & Co pay dividends?

Shionogi & Co pays a quarterly dividend. This is distributed in the months of October, April, October, April.

How secure is the dividend of Shionogi & Co?

Shionogi & Co paid dividends every year for the past 23 years.

What is the dividend of Shionogi & Co?

For the upcoming 12 months, dividends amounting to 117.56 JPY are expected. This corresponds to a dividend yield of 5.53 %.

In which sector is Shionogi & Co located?

Shionogi & Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shionogi & Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shionogi & Co from 12/2/2024 amounting to 28.333 JPY, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.

When did Shionogi & Co pay the last dividend?

The last dividend was paid out on 12/2/2024.

What was the dividend of Shionogi & Co in the year 2023?

In the year 2023, Shionogi & Co distributed 150 JPY as dividends.

In which currency does Shionogi & Co pay out the dividend?

The dividends of Shionogi & Co are distributed in JPY.